Page last updated: 2024-10-16

anthranilic acid and Pancreatic Neoplasms

anthranilic acid has been researched along with Pancreatic Neoplasms in 1 studies

anthranilic acid: RN given refers to parent cpd; structure in Negwer, 5th ed, #565
anthranilic acid : An aminobenzoic acid that is benzoic acid having a single amino substituent located at position 2. It is a metabolite produced in L-tryptophan-kynurenine pathway in the central nervous system.

Pancreatic Neoplasms: Tumors or cancer of the PANCREAS. Depending on the types of ISLET CELLS present in the tumors, various hormones can be secreted: GLUCAGON from PANCREATIC ALPHA CELLS; INSULIN from PANCREATIC BETA CELLS; and SOMATOSTATIN from the SOMATOSTATIN-SECRETING CELLS. Most are malignant except the insulin-producing tumors (INSULINOMA).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Roell, D1
Rösler, TW1
Hessenkemper, W1
Kraft, F1
Hauschild, M1
Bartsch, S1
Abraham, TE1
Houtsmuller, AB1
Matusch, R1
van Royen, ME1
Baniahmad, A1

Other Studies

1 other study available for anthranilic acid and Pancreatic Neoplasms

ArticleYear
Halogen-substituted anthranilic acid derivatives provide a novel chemical platform for androgen receptor antagonists.
    The Journal of steroid biochemistry and molecular biology, 2019, Volume: 188

    Topics: Androgen Receptor Antagonists; Animals; Cell Line, Tumor; Cell Proliferation; Chlorocebus aethiops;

2019